ORIC533

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameORIC533
Drug Alias NameORIC-533
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-nucleotidase inhibitors
Targets5'-nucleotidase
Therapy Area/IndicationsNeoplasm MetastasisMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOric Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOric Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A